3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On October 5, 2026, Nasdaq notified IB Acquisition Corp. that it is not compliant with Listing Rule 5620(a) because it has not held an annual shareholder meeting within twelve months of its fiscal year end. The company plans to submit a compliance plan within 45 calendar days, and Nasdaq can grant an exception until March 29, 2027. The notice has no immediate effect on the listing or trading of the common stock, which continues to trade as IBAC.
Nasdaq letter dated October 5, 2026 cites Listing Rule 5620(a), the Annual Meeting Requirement.
The company has 45 calendar days to submit a plan to regain compliance.
If the plan is accepted, Nasdaq can grant an exception until March 29, 2027.
Common stock continues to trade as IBAC on the Nasdaq Capital Market during the compliance period.
On October 6, 2026, HeartSciences said the FDA granted 510(k) clearance (K260005) for its MyoVista wavECG device as a 12-lead resting electrocardiograph, but the clearance does not include the AI-ECG algorithm. The company does not intend to commercialize the device without a cleared algorithm and has no timeline for doing so, and it will evaluate options for the device and related intellectual property. The proposed business combination with Fortitude Mining Holdings continues, with closing expected in Q4 calendar 2026, subject to shareholder approval.
FDA granted 510(k) clearance K260005 for the MyoVista wavECG device as a 12-lead resting electrocardiograph, covering adult and pediatric patients in hospitals and healthcare facilities.
The clearance does not include the AI-ECG algorithm, and the company has no commercialization timeline for the device.
The Proposed Transaction with Fortitude, under a merger agreement dated June 23, 2026, is expected to close in Q4 calendar 2026, subject to shareholder approval.
Virtuix Holdings Inc. (VTIX) received a Nasdaq notice on September 30, 2026, saying its market value of listed securities fell below the $50 million minimum for the Nasdaq Global Market. The company has until March 29, 2027 to regain compliance, and its shares continue to trade under VTIX for now. If it fails to meet the requirement, Nasdaq could begin delisting proceedings, which would put the stock's listing at risk.
Nasdaq notice dated September 30, 2026, based on market value of listed securities from August 18 to September 29, 2026
Minimum market value requirement is $50 million for continued listing on the Nasdaq Global Market
Compliance period runs until March 29, 2027, requiring at least ten consecutive business days at or above $50 million
Company also does not meet the alternative total assets and total revenue standard; it may apply to transfer to the Nasdaq Capital Market
A Florida state court set a December 14, 2026 hearing to decide whether to approve a proposed settlement of a shareholder derivative lawsuit and related derivative actions and demands brought on NextEra Energy's behalf. The settlement includes a $15.5 million cash payment to the company and corporate governance reforms, and it resolves claims that would otherwise continue against the individual defendants. Shareholders were notified of the proposal and their right to be heard at the hearing.
Court order dated September 22, 2026 set the Settlement Hearing for December 14, 2026 at 3:00 p.m.
Settlement consideration includes a $15.5 million cash payment to NextEra Energy and governance reforms set out in Exhibit A.
The Revised Stipulation of Settlement is dated July 29, 2026 and replaces the original stipulation dated June 11, 2026.
The hearing will also consider an agreed award of attorneys' fees and expenses for shareholder counsel.
Nasdaq's Listing Qualifications Staff determined to delist Kyntra Bio's common stock after the company did not show compliance with Listing Rule 5450(b) by the September 29, 2026 deadline. Kyntra Bio has requested a hearing before a Nasdaq Hearings Panel, and the stock will keep trading under KYNB while the Panel decides, so shareholders face continued uncertainty over the listing.
Staff determination letter dated September 30, 2026; compliance deadline was September 29, 2026
Company timely requested a Nasdaq Hearings Panel review, which stays the suspension and delisting
Extension period could be up to 180 days from the Staff determination under Listing Rule 5815(c)(1)(A)
Company previously received a April 2, 2026 notice on total assets, total revenue and stockholders' equity or market value standards; no assurance the Panel will grant continued listing
TELA Bio, Inc. received a letter from The Nasdaq Stock Market on October 5, 2026, stating that it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Market, and the matter is now closed. The company's common stock continues to trade on the Nasdaq Global Market under the symbol TELA, so shareholders face no change in listing status.
Nasdaq letter received October 5, 2026 confirms compliance with the minimum bid price requirement under Listing Rule 5450(a)(1)
Nasdaq matter is closed
Common stock continues to trade on the Nasdaq Global Market under the symbol TELA
Gulf Resources received a letter from Nasdaq's Listing Qualifications staff on October 1, 2026, stating it had regained compliance with the periodic filing requirement under Listing Rule 5250(c)(1) and that the staff determined it complies with the rule. The company announced the development in a press release dated October 6, 2026. For shareholders, this means the company's Nasdaq listing is no longer subject to this filing deficiency.
Nasdaq staff letter dated October 1, 2026 confirms compliance with Listing Rule 5250(c)(1)
Press release issued October 6, 2026 and filed as Exhibit 99.1
Company remains listed on The Nasdaq Capital Market per the press release
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.